UK HealthCare
Locations
Transplant Summary
Overview
The UK HealthCare Blood and Marrow Transplant Cell Therapy Program has highly-respected attending physicians with a full array of support staff. We focus on allogeneic transplants for acute and chronic leukemia and innovative GVHD prophylaxis regimens. We also offer CAR T therapy and several clinical trials.This center has been performing allogeneic transplants since 1982 and has been an NMDP transplant center since July 1987.
Attending physicians
Adult - Zena Chahine, Chaitanya Iragavarapu, Greg Monohan, Reinhold Munker, Ayman Qasrawi, Fevzi YalnizTransplants performed
Marrow/PBSC onlyCord blood transplants
Adult onlyOther programs and services
Cell Therapy ProgramPatient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 74 patients.The actual 1-year survival of these patients is 74.3%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 62.6% and 82%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
144
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC9Cord blood0Total9Unrelated donorMarrow0PBSC40Cord blood0Total40Total allogeneicMarrow0PBSC49Cord blood0Total49AutologousMarrowBoth marrow & PBSC 95PBSC—Cord blood—Total95Total combinedMarrowBoth marrow & PBSC 144PBSC—Cord blood0Total144All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44445-64565+0Total9Unrelated 0-18019-441545-641765+8Total40Autologous 0-18019-441945-645165+25Total95Total 0-18019-443845-647365+33Total144Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Markey Cancer Center Hematology Survivorship Clinic
800 Rose St Lexington, KY 40536 Phone:859-257-6006 Overview
Patients who have completed chemotherapy treatment, radiation treatment, and/or an autologous or allogeneic hematopoietic cell transplantation are eligible for survivorship program.
Staff
Program Director:Amy Scandrani, APRNProgram Coordinator:Amy Scandrani, APRNMedical Specialties in Program
Complementary and alternative medicine, hematology, oncology.Medical Services Offered
Chronic GVHD management, nutrition/dietetics, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 2 years after transplant.
- Adults (over age 19)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital